The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 21, 2021

Filed:

Jun. 21, 2017
Applicant:

The Curators of the University of Missouri, Columbia, MO (US);

Inventors:

Dongsheng Duan, Columbia, MO;

Yi Lai, Columbia, MO (US);

Junling Zhao, Columbia, MO (US);

Yongping Yue, Columbia, MO (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); A61K 35/28 (2015.01); A61K 9/00 (2006.01); A61P 25/14 (2006.01); C07K 14/47 (2006.01); C12N 15/62 (2006.01); C12N 5/0775 (2010.01); C12N 15/86 (2006.01); C12N 15/85 (2006.01); A61K 38/00 (2006.01); A61K 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 48/005 (2013.01); A61K 9/0019 (2013.01); A61K 35/28 (2013.01); A61K 48/00 (2013.01); A61P 25/14 (2018.01); C07K 14/4716 (2013.01); C12N 5/0663 (2013.01); C12N 15/62 (2013.01); C12N 15/85 (2013.01); C12N 15/86 (2013.01); A61K 35/00 (2013.01); A61K 38/00 (2013.01); C07K 2319/00 (2013.01); C07K 2319/01 (2013.01); C12N 2750/14143 (2013.01);
Abstract

Synthetic nucleic acids encoding mini and microdystrophin genes comprising the membrane binding motifs or domains of the R10-R11-R12 region are provided. Also provided are vectors, host cells, and related methods of using the same to treat a subject suffering from Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD) or X-linked dilated cardiomyopathy (XLDC), or for ameliorating one or more adverse effects of DMD, BMD, or XLDC. Also provided are a fusion protein comprising a nNOS binding domain of dystrophin R16-R17 that is operably linked to a syntrophin PDZ domain and synthetic nucleic acids comprising the same that can be used to treat subjects with diseases characterized by loss of sarcolemmal neuronal nitric oxide synthase (nNOS) activity.


Find Patent Forward Citations

Loading…